Endomyocardial Biopsy Market is projected to register a 7.4% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin Am
Continuous data are expressed as median (interquartile range) and compared using Kruskall & Wallis test. Categorical data are expressed as the frequency (%) and compared using Chi square test. Abbrevi
Aim: The aim of this study is to report recent trends in the performance of endomyocardial biopsy (EMB) and its in-hospital complications (and their predictors) in the United States (US)